Taisho Pharmaceutical Holdings Performance
| TAIPYDelisted Stock | USD 14.00 0.00 0.00% |
The entity has a beta of -0.67, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Taisho Pharmaceutical are expected to decrease at a much lower rate. During the bear market, Taisho Pharmaceutical is likely to outperform the market. Taisho Pharmaceutical right now has a risk of 0.0%. Please validate Taisho Pharmaceutical variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and kurtosis , to decide if Taisho Pharmaceutical will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Taisho Pharmaceutical Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Taisho Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 215.3 B | |
| Total Cashflows From Investing Activities | -7.1 B |
Taisho |
Taisho Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 1,400 in Taisho Pharmaceutical Holdings on September 15, 2024 and sell it today you would earn a total of 0.00 from holding Taisho Pharmaceutical Holdings or generate 0.0% return on investment over 90 days. Taisho Pharmaceutical Holdings is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Taisho, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Taisho Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Taisho Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Taisho Pharmaceutical Holdings, and traders can use it to determine the average amount a Taisho Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| TAIPY |
Based on monthly moving average Taisho Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Taisho Pharmaceutical by adding Taisho Pharmaceutical to a well-diversified portfolio.
Taisho Pharmaceutical Fundamentals Growth
Taisho Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Taisho Pharmaceutical, and Taisho Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Taisho Pink Sheet performance.
| Return On Equity | 0.0345 | |||
| Return On Asset | 0.0183 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 1.27 B | |||
| Shares Outstanding | 327.94 M | |||
| Price To Earning | 20.67 X | |||
| Price To Book | 0.57 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 268.2 B | |||
| EBITDA | 42.81 B | |||
| Cash And Equivalents | 276.54 B | |||
| Cash Per Share | 843.28 X | |||
| Book Value Per Share | 2,413 X | |||
| Cash Flow From Operations | 28.51 B | |||
| Earnings Per Share | 0.49 X | |||
| Total Asset | 888.16 B | |||
About Taisho Pharmaceutical Performance
Evaluating Taisho Pharmaceutical's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Taisho Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Taisho Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Taisho Pharmaceutical Holdings Co., Ltd., through its subsidiaries, researches, develops, manufactures, markets, distributes, and sells over-the-counter drugs and prescription pharmaceutical products in Japan and internationally. Taisho Pharmaceutical Holdings Co., Ltd. was founded in 1912 and is headquartered in Tokyo, Japan. Taisho Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 9134 people.Things to note about Taisho Pharmaceutical performance evaluation
Checking the ongoing alerts about Taisho Pharmaceutical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Taisho Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Taisho Pharmaceutical is not yet fully synchronised with the market data | |
| Taisho Pharmaceutical has a very high chance of going through financial distress in the upcoming years |
- Analyzing Taisho Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Taisho Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Taisho Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Taisho Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Taisho Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Taisho Pharmaceutical's pink sheet. These opinions can provide insight into Taisho Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Taisho Pink Sheet
If you are still planning to invest in Taisho Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taisho Pharmaceutical's history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |